Jennifer Clarke

InstitutionBeaumont Hospital
AddressDublin
Ireland
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 2 publications in November 2020
    All Publications
    Bar chart showing 183 publications over 20 distinct years, with a maximum of 22 publications in 2012
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Palmas F, Clarke J, Colas RA, Gomez EA, Keogh A, Boylan M, McEvoy N, McElvaney OJ, McElvaney O, Alalqam R, McElvaney NG, Curley GF, Dalli J. Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients. PLoS One. 2021; 16(8):e0256226. PMID: 34437568.
      Citations: 1     Fields:    Translation:HumansCells
    2. Hogan G, Geoghegan P, Carroll TP, Clarke J, McElvaney OF, McElvaney OJ, McElvaney NG, Curley GF. a1-Antitrypsin: Key Player or Bystander in Acute Respiratory Distress Syndrome? Anesthesiology. 2021 05 01; 134(5):792-808. PMID: 33721888.
      Citations:    Fields:    Translation:HumansAnimalsCells
    3. McEvoy NL, Clarke JL, Mc Elvaney OJ, Mc Elvaney OF, Boland F, Hyland D, Geoghegan P, Donnelly K, Friel O, Cullen A, Collins AM, Fraughen D, Martin-Loeches I, Hennessy M, Laffey JG, Mc Elvaney NG, Curley GF. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial. Trials. 2021 Apr 19; 22(1):288. PMID: 33874981.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    4. Martin RA, Stein LAR, Rohsenow DJ, Belenko S, Hurley LE, Clarke JG, Brinkley-Rubinstein L. Using implementation interventions and peer recovery support to improve opioid treatment outcomes in community supervision: Protocol. J Subst Abuse Treat. 2021 09; 128:108364. PMID: 33741216.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    5. Clarke J, Geoghegan P, McEvoy N, Boylan M, Ní Choileáin O, Mulligan M, Hogan G, Keogh A, McElvaney OJ, McElvaney OF, Bourke J, McNicholas B, Laffey JG, McElvaney NG, Curley GF. Prone positioning improves oxygenation and lung recruitment in patients with SARS-CoV-2 acute respiratory distress syndrome; a single centre cohort study of 20 consecutive patients. BMC Res Notes. 2021 Jan 09; 14(1):20. PMID: 33422143.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    6. Ward SE, Curley GF, Lavin M, Fogarty H, Karampini E, McEvoy NL, Clarke J, Boylan M, Alalqam R, Worrall AP, Kelly C, de Barra E, Glavey S, Ni Cheallaigh C, Bergin C, Martin-Loeches I, Townsend L, Mallon PW, O'Sullivan JM, O'Donnell JS. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation. Br J Haematol. 2021 02; 192(4):714-719. PMID: 33326604.
      Citations: 23     Fields:    Translation:HumansCells
    7. McElvaney OJ, O'Connor E, McEvoy NL, Fraughan DD, Clarke J, McElvaney OF, Gunaratnam C, O'Rourke J, Curley GF, McElvaney NG. Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19. J Cyst Fibros. 2021 01; 20(1):31-35. PMID: 33288475.
      Citations: 4     Fields:    Translation:Humans
    8. McElvaney OJ, Hobbs BD, Qiao D, McElvaney OF, Moll M, McEvoy NL, Clarke J, O'Connor E, Walsh S, Cho MH, Curley GF, McElvaney NG. Corrigendum to 'A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19'. EBioMedicine. 2020 Dec; 62:103116. PMID: 33181463.
      Citations:    Fields:    
    9. McElvaney OJ, Hobbs BD, Qiao D, McElvaney OF, Moll M, McEvoy NL, Clarke J, O'Connor E, Walsh S, Cho MH, Curley GF, McElvaney NG. A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19. EBioMedicine. 2020 Nov; 61:103026. PMID: 33039714.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    10. Citations: 139     Fields:    Translation:HumansCellsPHPublic Health